☆GordonMD Global Investments LP
Quality Q
0.393
AUM ($M)
207
Positions
16
Turnover
0.24
Top-10 wt
84%
Herfindahl
0.096
History (qtrs)
3
Excess Return
—
AI Eval Run AI Eval
Holdings · 17 positions · portfolio value $207M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆KYTX funds › | KYVERNA THERAPEUTICS INC | HOLD | — | 18.3% | -7.2% | 37.8 | 4,244,818 | +0 | 2 | — |
| ☆PYXS funds › | PYXIS ONCOLOGY INC | ADD | — | 14.6% | +10.4% | 30.2 | 10,024,909 | +5,903,039 | 2 | — |
| ☆TSHA funds › | TAYSHA GENE THERAPIES INC | TRIM | — | 11.9% | -3.6% | 24.5 | 723,185 | -14,365 | 2 | — |
| ☆TEVA funds › | TEVA PHARMACEUTICAL INDS LTD | ADD | — | 7.9% | +4.0% | 16.4 | 2,402,495 | +1,145,000 | 2 | — |
| ☆VIR funds › | VIR BIOTECHNOLOGY INC | TRIM | — | 6.7% | -2.8% | 13.8 | 1,353,552 | -165,000 | 2 | — |
| ☆ALLO funds › | ALLOGENE THERAPEUTICS INC | ADD | — | 5.3% | +2.9% | 11.0 | 5,298,000 | +3,868,000 | 2 | — |
| ☆CLDX funds › | CELLDEX THERAPEUTICS INC NEW | ADD | — | 5.0% | +1.3% | 10.4 | 279,720 | +109,413 | 2 | — |
| ☆EDIT funds › | EDITAS MEDICINE INC | NEW | — | 4.9% | +4.9% | 10.1 | 3,127,000 | +3,127,000 | 1 | — |
| ☆RARE funds › | ULTRAGENYX PHARMACEUTICAL IN | HOLD | — | 4.7% | +0.5% | 9.7 | 289,101 | +0 | 2 | — |
| ☆BLCO funds › | BAUSCH PLUS LOMB CORP | HOLD | — | 4.6% | -1.8% | 9.5 | 573,472 | +0 | 2 | — |
| ☆AMGN funds › | AMGEN INC | HOLD | — | 3.5% | -1.4% | 7.3 | 20,212 | +0 | 2 | — |
| ☆SRRK funds › | SCHOLAR ROCK HLDG CORP | HOLD | — | 3.5% | -1.0% | 7.3 | 132,500 | +0 | 2 | — |
| ☆SION funds › | SIONNA THERAPEUTICS INC | HOLD | — | 2.9% | -0.9% | 6.0 | 136,000 | +0 | 2 | — |
| ☆INCY funds › | INCYTE CORP | HOLD | — | 2.4% | -0.5% | 4.9 | 43,300 | +0 | 2 | — |
| ☆CRNX funds › | CRINETICS PHARMACEUTICALS IN | HOLD | — | 2.3% | -0.9% | 4.8 | 126,985 | +0 | 2 | — |
| ☆INSM funds › | INSMED INC | HOLD | — | 1.5% | -1.8% | 3.0 | 28,587 | +0 | 2 | — |
| ☆TARS funds › | TARSUS PHARMACEUTICALS INC | EXIT | — | 0.0% | -2.1% | 0.0 | 0 | -42,680 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 207 | 16 | 0.24 | 84% | 0.096 | 0.394 | — | in |
| 2026Q1 | 144 | 16 | 0.28 | 82% | 0.118 | 0.275 | — | entered |
| 2025Q4 | 139 | 13 | 0.00 | 90% | 0.145 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status